Corina van den Hurk

Netherlands Comprehensive Cancer Organisation

Corina van den Hurk is an occupational therapist who studied health science at Maastricht University in the Netherlands, with a master degree in movement science and epidemiology. After graduation she worked at the Comprehensive Cancer Centre the Netherlands, first as a cancer registrar and thereafter as a researcher on a project on quality of care in breast cancer.

She started research on scalp cooling at Leiden University Medical Centre and the Comprehensive Cancer Centre the Netherlands in 2005 and finished her PhD on scalp cooling in 2013.

From 2009 to 2013 she was also assistant coordinator of the EU-FP7 project EUROpe against Cancer: Optimisation of the Use of Registries for Scientific Excellence in research (EUROCOURSE).

dont miss

Hair loss through chemotherapy is not inevitable!

Chemotherapy-induced alopecia is a side effect with high impact for many cancer patients. In Europe scalp cooling has been used to prevent hair loss for over a decade and is increasingly being applied worldwide. A registry containing data of more than 5,000 scalp cooled breast cancer patients shows varying success rates depending on type and dose of chemotherapy. Determinants of efficacy as well as safety and cost-effectiveness will be discussed.

Corina van den Hurk will be speaking in the following theatre:

Theatre 12 - Tuesday 11.45 - 12.15: Hair loss through chemotherapy is not inevitable!

EVEN MORE SEMINARS

  • Dr Keith Tsui: Speaking at the Oncology Convention

    Dr Keith Tsui
    Medopad

    Remote Patient Monitoring: Bringing the Hospital into the Home

  • Christopher Curtis: Speaking at the Oncology Convention

    Christopher Curtis
    The Swallows Head & Neck Cancer Charity

    From Cancer to the Palace in 6 years

  • Dr Nathan Hill & Dr James Watson: Speaking at the Oncology Convention

    Dr Nathan Hill & Dr James Watson
    MedInfomatics Ltd

    Electronic Medical Records – have they lived up to expectations?

  • Professor Hisham Mehanna: Speaking at the Oncology Convention

    Professor Hisham Mehanna
    InHANSE, Institute of Cancer and Genomic Sciences, University of Birmingham

    Clinical trials that change patient care and the lessons learnt

  • Ms Claire Barnard: Speaking at the Oncology Convention

    Ms Claire Barnard
    GenesisCare

    Surface-Guided Radiotherapy and Optimal Breast Cancer Treatment